Approach enlists immune system to fight leukemia
CHICAGO (Reuters) - Leukemia patients may be able to avoid developing resistance to the drug Gleevec through a mathematical formula that predicts when they should receive an immune-boosting vaccine, researchers said on Thursday.
<p><img src="http://feeds.feedburner.com/~a/reuters/healthNews?i=d1IH1U" border="0"></img> (http://feeds.feedburner.com/~a/reuters/healthNews?a=d1IH1U)</p><div class="feedflare">
<img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=5Jdj0I" border="0"></img> (http://feeds.feedburner.com/~f/reuters/healthNews?a=5Jdj0I) <img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=WYfQRi" border="0"></img> (http://feeds.feedburner.com/~f/reuters/healthNews?a=WYfQRi) <img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=7Pwnli" border="0"></img> (http://feeds.feedburner.com/~f/reuters/healthNews?a=7Pwnli)
</div><img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/315823184" height="1" width="1"/>
http://feeds.feedburner.com/~r/reuters/healthNews/~3/315823184/idUSN1932621420080620